BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21290423)

  • 1. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
    Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
    Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
    Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
    Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
    Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
    J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors.
    Zhao Y; Liu Y; Chen D; Wei Z; Liu W; Gong P
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7230-3. PubMed ID: 21074429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.
    Jia W; Liu Y; Li W; Liu Y; Zhang D; Zhang P; Gong P
    Bioorg Med Chem; 2009 Jul; 17(13):4569-74. PubMed ID: 19457674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.
    Li YF; Wang GF; Luo Y; Huang WG; Tang W; Feng CL; Shi LP; Ren YD; Zuo JP; Lu W
    Eur J Med Chem; 2007; 42(11-12):1358-64. PubMed ID: 17499889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
    Luo Y; Xiao F; Qian S; Lu W; Yang B
    Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
    Qu SJ; Wang GF; Duan WH; Yao SY; Zuo JP; Tan CH; Zhu DY
    Bioorg Med Chem; 2011 May; 19(10):3120-7. PubMed ID: 21524588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
    Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
    Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in-vitro anti-hepatitis B virus activity of ethyl 6-bromo-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylates.
    Chen D; Liu Y; Zhang S; Guo D; Liu C; Li S; Gong P
    Arch Pharm (Weinheim); 2011 Mar; 344(3):158-64. PubMed ID: 21384414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols.
    Jia W; Zhao Y; Li R; Wu Y; Li Z; Gong P
    Arch Pharm (Weinheim); 2009 Sep; 342(9):507-12. PubMed ID: 19637181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-hepatitis B activity of new substituted uracil and thiouracil glycosides.
    Abdel-Aal MT
    Arch Pharm Res; 2010 Jun; 33(6):797-805. PubMed ID: 20607483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
    Xu B; Huang Z; Liu C; Cai Z; Pan W; Cao P; Hao X; Liang G
    Bioorg Med Chem; 2009 Apr; 17(8):3118-25. PubMed ID: 19307124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
    Xue F; Luo X; Ye C; Ye W; Wang Y
    Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs.
    Zhang Y; Zhong H; Lv Z; Zhang M; Zhang T; Li Q; Li K
    Eur J Med Chem; 2013 Apr; 62():158-67. PubMed ID: 23353737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
    Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
    Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
    Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
    Cheng J; Xie J; Luo X
    Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro.
    Liu Y; Zhao Y; Zhai X; Feng X; Wang J; Gong P
    Bioorg Med Chem; 2008 Jul; 16(13):6522-7. PubMed ID: 18524601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors.
    Zhang Q; Jiang ZY; Luo J; Ma YB; Liu JF; Guo RH; Zhang XM; Zhou J; Niu W; Du FF; Li L; Li C; Chen JJ
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6659-65. PubMed ID: 19853440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.